2235-0073 Screening compound: 2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]-N'-[(E)-(pyridin-2-yl)methylidene]acetohydrazide

2235-0073 Screening compound: 2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]-N'-[(E)-(pyridin-2-yl)methylidene]acetohydrazide
2235-0073 Screening compound: 2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]-N'-[(E)-(pyridin-2-yl)methylidene]acetohydrazide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2235-0073
2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]-N'-[(E)-(pyridin-2-yl)methylidene]acetohydrazide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2235-0073

Molecular Formula

C20H16N6O (C20 H16 N6 O)

Compound Name

2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]-N'-[(E)-(pyridin-2-yl)methylidene]acetohydrazide

IUPAC name

2-[2-(pyridin-2-yl)-1H-13-benzodiazol-1-yl]-N'-[(E)-(pyridin-2-yl)methylidene]acetohydrazide

SMILES

O=C(Cn1c(-c2ncccc2)nc2c1cccc2)N/N=C/c1ncccc1

InChI

InChI=1S/C20H16N6O/c27-19(25-23-13-15-7-3-5-11-21-15)14-26-18-10-2-1-8-16(18)24-20(26)17-9-4-6-12-22-17/h1-13H,14H2,(H,25,27)

InChI Key

MJUMMQUFYHXGMJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01535116

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

356.39

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.362

Distribution Coefficient, logD

2.344

Water Solubility, LogSw

-2.65

Polar Surface Area

63.860

Acid Dissociation Constant (pKa)

10.08

Base Dissociation Constant (pKb)

6.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.00

2235-0073 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 2235-0073 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2235-0073?
Check Price and Availability of 2235-0073, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2235-0073 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2235-0073
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2235-0073
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2235-0073 available by request